Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol Paying $2 Bil. For ImClone C225; New Milestone For Inlicensing Deals?

Sep 24 2001

• By The Pink Sheet

Related Content

ImClone C225 Compassionate Use On Hold Pending New Manufacturing Plant

Jun 25 2001

Pharmacia/Celltech Anti-TNF Antibody Deal Includes $50 Mil. Up Front

Mar 12 2001

GlaxoSmithKline Is Mouthful But Still Hungry: Is Next Course Japanese?

Feb 26 2001

AstraZeneca To "Go It Alone" For Crestor, Cites Large Market Opportunity

Jul 30 2001

Genentech Will Market OSI Cancer Drug In U.S. Under Three-Way Deal

Jan 15 2001

Bristol/DuPont Is Timely Deal: Will Disrupt Difficult 2002, Add To 2003

Jun 11 2001

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window